Literature DB >> 2154346

Natural killer cell activity, interferon-gamma and antibodies to herpes viruses in patients with Behçet's disease.

K Hamzaoui1, K Ayed, A Slim, M Hamza, J Touraine.   

Abstract

Interferon-gamma (IFN-gamma) titres in 20 patients with active Behçet's disease were examined and compared with those of 20 normal donors. Sera from Behçet's disease patients revealed an IFN-gamma increase but no correlation between IFN level and natural killer (NK) activity. The analysis of lymphocyte subsets by monoclonal antibodies registered an increase of CD8+ T subpopulation and cells co-expressing CD8(+)-Leu7a+ markers. Moreover, a high number of cells expressing CD25+ and HLA-DR+ phenotype has been noted in patients with active Behçet's disease. Serological analysis showed a high level of IgG antibodies to HSV-1. The increase of IFN-gamma titre, the high number of activated T cells and the increasing level of IgG antibodies to HSV-1 are important manifestations during the active stage of Behçet's disease. These findings are discussed in relation to the immunopathogenesis of Behçet's disease.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2154346      PMCID: PMC1534721          DOI: 10.1111/j.1365-2249.1990.tb05122.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  14 in total

Review 1.  Infection and rheumatic diseases.

Authors:  M A Rodriguez; R C Williams
Journal:  Clin Exp Rheumatol       Date:  1989 Jan-Feb       Impact factor: 4.473

2.  Natural killer cells in Behçet's disease.

Authors:  K Hamzaoui; K Ayed; M Hamza; J L Touraine
Journal:  Clin Exp Immunol       Date:  1988-01       Impact factor: 4.330

3.  Lymphocyte interferon production and transformation after Herpes simplex infections in humans.

Authors:  L E Rasmussen; G W Jordan; D A Stevens; T C Merigan
Journal:  J Immunol       Date:  1974-02       Impact factor: 5.422

4.  Lymphocyte abnormalities in Behçet's syndrome.

Authors:  A M Denman; P J Fialkow; B K Pelton; A C Salo; D J Appleford; C Gilchrist
Journal:  Clin Exp Immunol       Date:  1980-10       Impact factor: 4.330

5.  CD4 and CD8 cell responses to herpes simplex virus in Behçet's disease.

Authors:  C Young; T Lehner; C G Barnes
Journal:  Clin Exp Immunol       Date:  1988-07       Impact factor: 4.330

6.  Detection of RNA complementary to herpes-simplex virus in mononuclear cells from patients with Behçet's syndrome and recurrent oral ulcers.

Authors:  R P Eglin; T Lehner; J H Subak-Sharpe
Journal:  Lancet       Date:  1982-12-18       Impact factor: 79.321

7.  Interferon-gamma production by peripheral blood mononuclear cells from patients with Behçet's syndrome.

Authors:  T H Bacon; F Ozbakir; C A Elms; A M Denman
Journal:  Clin Exp Immunol       Date:  1984-09       Impact factor: 4.330

Review 8.  Behçet disease (Behçet syndrome).

Authors:  T Shimizu; G E Ehrlich; G Inaba; K Hayashi
Journal:  Semin Arthritis Rheum       Date:  1979-05       Impact factor: 5.532

9.  2',5'-oligoadenylate synthetase induction in lymphocytes of patients with connective tissue diseases.

Authors:  W Hylton; J Cayley; C Dore; A M Denman
Journal:  Ann Rheum Dis       Date:  1986-03       Impact factor: 19.103

10.  In vivo activated peripheral T cells in autoimmune disease.

Authors:  A Raedler; G Bredow; W Kirch; H G Thiele; H Greten
Journal:  J Clin Lab Immunol       Date:  1986-04
View more
  17 in total

1.  Expression of Bcl-2 in inflammatory sites from patients with active Behçet's disease.

Authors:  K Hamzaoui; A Hamzaoui; L Zakraoui; A Chabbou
Journal:  Mediators Inflamm       Date:  1999       Impact factor: 4.711

Review 2.  Pathogenesis of Adamantiades-Behçet's disease.

Authors:  Christos C Zouboulis; Tobias May
Journal:  Med Microbiol Immunol       Date:  2003-03-05       Impact factor: 3.402

3.  Excessive expression of Txk, a member of the Tec family of tyrosine kinases, contributes to excessive Th1 cytokine production by T lymphocytes in patients with Behcet's disease.

Authors:  H Nagafuchi; M Takeno; H Yoshikawa; M S Kurokawa; K Nara; E Takada; C Masuda; M Mizoguchi; N Suzuki
Journal:  Clin Exp Immunol       Date:  2005-02       Impact factor: 4.330

4.  Cytotoxic T cells against herpes simplex virus in Behçet's disease.

Authors:  K Hamzaoui; A Kahan; K Ayed; M Hamza
Journal:  Clin Exp Immunol       Date:  1990-09       Impact factor: 4.330

Review 5.  Skewed Th1 responses caused by excessive expression of Txk, a member of the Tec family of tyrosine kinases, in patients with Behcet's disease.

Authors:  Noboru Suzuki; Kazuhiko Nara; Tomoko Suzuki
Journal:  Clin Med Res       Date:  2006-06

6.  Elevated levels of soluble intercellular adhesion molecule-1 correlate with disease activity in Behçet's disease.

Authors:  A O Aydintuğ; G Tokgöz; K Ozoran; N Düzgün; A Gürler; H Tutkak
Journal:  Rheumatol Int       Date:  1995       Impact factor: 2.631

7.  Gene expression of tumour necrosis factor-alpha (TNF-alpha) and heat-shock protein (HSP) 70 in patients with Behçet's disease.

Authors:  Y Yamakawa; Y Sugita; Y Takahashi; T Yamakawa; S Tanaka; S Nakamura; J Fukushima; S Kawamoto; S Ohno; K Okuda
Journal:  Arch Dermatol Res       Date:  1993       Impact factor: 3.017

8.  Serum levels of interleukin-8 in patients with Behcet's disease.

Authors:  K Ozoran; O Aydintuğ; G Tokgöz; N Düzgün; H Tutkak; A Gürler
Journal:  Ann Rheum Dis       Date:  1995-07       Impact factor: 19.103

9.  Abnormal killer inhibitory receptor expression on natural killer cells in patients with Behçet's disease.

Authors:  Mitsuhiro Takeno; Yoshihiro Shimoyama; Jun-Ichi Kashiwakura; Hiroko Nagafuchi; Tsuyoshi Sakane; Noboru Suzuki
Journal:  Rheumatol Int       Date:  2003-07-15       Impact factor: 2.631

10.  Polymorphic sites away from the Bw4 epitope that affect interaction of Bw4+ HLA-B with KIR3DL1.

Authors:  Bharati Sanjanwala; Monia Draghi; Paul J Norman; Lisbeth A Guethlein; Peter Parham
Journal:  J Immunol       Date:  2008-11-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.